A technique developed for analysis of less than microgram quantities of tRNA has been applied to the study of human leukemia. Leucocytes from peripheal blood and bone marrow samples of six, untreated leukemia patients and cells of five different established human cell lines were maintained for 18 hours in media containing [32p]_phosphate. Incorporation of radioactive phosphate into the cells from the patient samples was slightly less than that of the cell lines. Likewise, incorporation of [ 32 p]-phosphate into the tRNA of the patient samples (approximately 5 x 10 6 DPM/yg tRNA) was also less than that incorporated into the tRNA of the cell lines. The major and minor nucleotide compositions of the unfractionated tRNA preparations from each patient sample and each cell line were determined and compared. Similarities and differences in the major and minor nucleotide compositions of the tRNA preparations are discussed with reference to types of leukemia and the importance of patient sample analysis versus analysis of cultured human cells.
INTRODUCTION
Mammalian cells undergo changes in protein synthesis which are associated with such phenomena as differentiation (1) , hormonal stimulation (2), aritigenic stimulation (3), regeneration (4), aging (5) and viral transformation (6) . Changes in the amount and types of proteins being synthesized by cells are accompanied by changes in the cellular population of tRNA molecules (7, 8) . The role of tRNA in protein synthesis as translator of the genetic code into the amino acid sequences of proteins has been well documented (9) .
Of recent interest are those investigations that have demonstrated the involvement of tRNA in the regulation of cellular processes (10) and the replication of RNA tumor viruses (11, 12) . Thus comparison of tRNA molecules from normal, non-differentiating cells with that from differentiating, neoplastic or transformed cells is important to our understanding of the involvement of tRNA in these cellular phenomena. Analysis of tRNA molecules from mammalian cells (other than human) or from cells in culture is possible (13) . Analysis of tRNA molecules from human cell samples is difficult because the cell sample size is usually very small unless the cells are subsequently adapted to culture, a procedure which takes considerable time and alters cell morphology and biochemistry (14) . Techniques for the analysis of tRNA from small numbers of cells (1 x 10 ) have already been reported by Agris ejt a_l^. (13) . The present investigation reports on the adaptation of these techniques to the analysis of tRNA from peripheal blood and bone marrow samples of human leukemia patients.
MATERIALS AND METHODS

Materials.
Cell media, including a specially prepared phosphate-free minimal essential medium (13) , and fetal calf serum were purchased from Grand Island Biological; [ 
Separation of Leucocytes from Peripheal Blood and Bone Marrow Samples.
Peripheal blood and bone marrow samples taken from untreated, leukemia patients were kept in heparinized syringes left in an upright position for 2-3 hr at room temperature. Red blood cells settled, the leucocyte fraction was removed under sterile conditions and subjected to centrifugation (lOOOg for 10 min). The resulting white blood cell samples were resuspended in sterile saline and collected again by centrifugation before being placed in radioactive medium. on the tic plates were determined by autoradiography and compared to that of standards (15) . The relative amounts of each of the nucleotides was analyzed by scraping the cellulose areas that corresponded to the exposed regions of the autoradiograph and determining the radioactivity in the cellulose by scintillation counting. Only one peripheal blood or bone marrow sample could be obtained before the patients were clinically treated. For all practical purposes this imposed a limit of one tRNA analysis for each sample. However, the nucleotide compositions of tRNA from the cell lines were determined as many as four times. The degree of error in such determinations is discussed below.
RESULTS
Incorporation of [ P]-phosphate into tRNA.
Peripheal blood and bone marrow samples from patients suffering from either lymphoblastic or myelogenous leukemias were obtained from local hospitals. The sample designations (H.L. I, II, etc.) and the types of leukemia as diagnosed by the hospital staff physicians are shown in Table I . Leucocytes were separated from the samples and maintained for 18 hr in medium containing f Pi-phosphate as described in Materials and Methods. Commercially available human cell lines (Table I) including a white blood cell line (RPMI 6410) were also maintained for 18 hr in the radioactive medium. The amount of radioactive phosphate incorporated by the cells was determined by analysis of that remaining in the medium after the incubation period. In general 56% of the radioactive phosphate in the medium was taken up by the cells as shown in Table II . However, the cell lines incorporated slightly more phosphate (an average of 59% of the in a manner similar to that incorporated into total nucleic acids (Table II) . This difference in Gp plus Cp content seems to be caused more by differences in Gp than Cp as evidenced by the amounts of these nucleotides as reported in Table III (Table III) . A capability to determine the minor nucleotide compositions of tRNA from patient cell samples is also important because the minor nucleotides of tRNA have been implicated in regulatory processes. In particular, Vp in tRNA has been shown to be involved in repressing the synthesis of enzymes for certain 6 ami no acid biosynthetic pathways (17, Iff, 19) . i Ap, in those tRNA species which respond to codons beginning with Up, was found to effect, in a positive manner, the binding of tRNA to ribosomes (20) . Eucaryotic tRNA species responsible for initiation of protein synthesis have been shown to lack riboTp (21) . The presence of a particular minor species of tRNA has been shown to be correlated with a mammalian cell's ability to divide (22, 23) . Structural differences between this isoaccepting species of tRNA Table III indicate that there are significant differences in the minor nucleotide amounts present in tRNA from lymphoblastic and myelogenous leukemia samples. Interestingly, the greatest differences between the nucleotide composition of tRNA from a peripheal blood sample and a bone marrow sample from the same patient were differences in minor nucleotide amounts. This result could indicate that the tRNA samples are essentially the same but involved in different regulatory processes.
The analytical technique employed has been shown to be applicable to the small numbers of cells obtained in human samples thereby eliminating the need for culturing of cells. The adaptation of r-ells to culture changes cell morphology and biochemistry (14) . In fact, the nucleotide compositions of the 
